2004

Mar 7, 2004
Guidant's Carotid Artery Stenting Trials Demonstrate Positive Outcomes in High-Risk Patients as Alternative to Surgery to Reduce the Risk of Stroke

Results Presented Today at American College of Cardiology Conference in New Orleans Indianapolis, Ind., and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT), a world leader in the treatment...

Mar 3, 2004
Guidant to Host Investor Briefing at 2004 American College of Cardiology Annual Scientific Session

Company Will Announce Final Results of Studies Evaluating New Stroke Prevention Technology at Late-Breaking Clinical Trials Session Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world...

Feb 25, 2004
Guidant Elects Jack A. Shaw to Board of Directors

INDIANAPOLIS - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, announced today that its board of directors has elected Jack A. Shaw, retired...

Feb 24, 2004
Guidant Gains Immediate Access to Drug Eluting Stent Market

Agreement with Cordis, a Johnson & Johnson Company, Strengthens Guidant''s Broad Product Portfolio; Live Webcast Available Today at 9:00 AM EST Indianapolis, Ind. - Guidant Corporation (NYSE:...

Feb 20, 2004
Guidant Announces Settlement of All Litigation With Boston Scientific

Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it has entered into an agreement with Boston Scientific...

Feb 17, 2004
Guidant Increases Quarterly Dividend

Company Announces Share Repurchase Program INDIANAPOLIS - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that the company''s...

Jan 29, 2004
Guidant Reports Record Fourth Quarter Sales of $951 million, 8 Percent Sales Growth; Record Full-Year 2003 Sales of $3.7 billion, 17 Percent Sales Growth

Fourth quarter highlights: Worldwide implantable defibrillator revenue of $396 million, up 30 percent Worldwide stent revenue of $202 million, down 17 percent; up 2 percent versus third quarter...

Jan 29, 2004
Guidant Announces U.S. Launch of Cardiac Resynchronization Therapy Pacemaker

Guidant Receives FDA Approval Based on COMPANION Clinical Trial Data Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and...

Jan 28, 2004
Guidant to Participate in the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference

Presentation Accessible Via Webcast Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will participate...

Jan 22, 2004
Guidant Announces Agreement to Acquire Surgical Cardiac Ablation Company

Acquisition Positions Guidant to Enter New Therapy Area Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular...

Show per page

Top